CPIX - Cumberland Pharmaceuticals Inc logo

CPIX

Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals develops and commercializes prescription products, including Acetadote for acetaminophen poisoning and Caldolor for pain and fever. It serves the hospital, gastroenterology, and oncology markets across multiple countries.

โš•๏ธ Healthcare NASDAQ Listed 2009 $ USD
$1,000 invested 10 years ago โ†’$2,905today

Score Overview

1 Year
Score
Net Growth-273.98%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-29.77%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.2
Net Growth-202.39%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth-13.11%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-9x
Net Trend40%
Net Income Consistency
Rev Growth-5.32%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-443.09%
Net Trend41%
Net Income Consistency
Rev Growth-28.18%
Rev Trend41%
Revenue Consistency

See the full market ranking โ†’

Cumberland Pharmaceuticals Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 37M to $ 44M and net income went from -$ 3M to -$ 2M. Revenue increased in 2 of those 5 years; net income in 1.

Across Cumberland Pharmaceuticals Inc's full reported history, from 2009 to 2025, revenue grew from $ 43M to $ 44M and net income went from $ 3M to -$ 2M. Revenue increased in 41% of the years measured; net income in 41%.

Cumberland Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 7.91โ€”
1 Year2025-08-12
$ 1.78344.18%
5 Years2021-08-12
$ 1.76348.79%
10 Years2016-08-12
$ 2.72190.46%
All Time2009-08-11
$ 10.30-23.20%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 31M-$ 10M$ 3M
2025$ 44M-$ 2M$ 11M
2024$ 37M-$ 6M$ 17M
2023$ 39M-$ 6M$ 18M
2022$ 42M-$ 5M$ 19M
2021$ 35M-$ 3M$ 27M
2020$ 37M-$ 3M$ 24M
2019$ 34M-$ 3M$ 28M
2018$ 40M-$ 6M$ 36M
2017$ 41M-$ 7M$ 50M
2016$ 33M-$ 944.68K$ 50M
2015$ 33M$ 731.35K$ 52M
2014$ 36M$ 2M$ 54M
2013$ 32M-$ 2M$ 54M
2012$ 48M$ 5M$ 71M
2011$ 51M$ 5M$ 70M
2010$ 45M$ 2M$ 65M
IPO2009$ 43M$ 3M$ 78M

Explore beyond CPIX

You're looking at Cumberland Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies